Compare Cisco Systems Inc (CSCO) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cisco Systems Inc vs Medpace Holdings Inc — how do they compare? Cisco Systems Inc trades at $117.09 (market cap $461.50B), while Medpace Holdings Inc trades at $536.29 (market cap $15.31B). The key difference: Cisco Systems Inc is far larger — about 30.1× Medpace Holdings Inc's market cap, and Cisco Systems Inc pays a 1.43% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| CSCO | MEDP | |
|---|---|---|
Market Cap | $461.50B | $15.31B |
Volume | 22,887,319 | — |
Sector | Technology | Technology |
52-Week High | $130.00 | $620.59 |
52-Week Low | $66.20 | $308.88 |
Enterprise Value | $476.17B | $14.78B |
Dividend Yield | 1.43% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cisco Systems (CSCO) trades at $117.09, down 3.48% over 24 hours, with a bullish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.06 exceeding the $1.03 estimate. Revenue for 2025 was $56.65 billion, with a net income margin of 19.69%. Recent news highlights Cisco's strategic AI and cybersecurity partnerships, positioning it for growth in the networking and security markets.
The outlook for CSCO is positive, supported by analyst consensus with a $130.38 price target and 52% buy ratings. Key opportunities include AI-driven security demand and solid cash flow. Risks involve competitive pressures and debt levels, with a debt-to-asset ratio of 22.97% in 2025. Investors should weigh strong fundamentals against market volatility and execution risks.
MEDP trades at $530.19, down 1.49% on the day, with a bullish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 results expected on July 22, 2026. Fundamentals show robust profitability with a 17.19% net income margin and 77.25% ROE, though valuation ratios like P/E of 33.74 are elevated. Recent news highlights volatility and a class action lawsuit filed in June 2026.
Outlook is mixed; earnings momentum and high profitability support upside, but high valuation and legal overhang pose risks. Analyst consensus is cautious with a $497 price target below current levels, suggesting limited near-term gains. Investors should weigh strong operational performance against valuation concerns and litigation risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cisco Systems Inc
Cisco Systems, Inc. provides information technology and networking services. The Company offers enterprise network security, software development, data collaboration, cloud computing, and other related services. Cisco Systems serves customers in the United States.
Read more on CSCO →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
